| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 9 May 2026 | 9 May 2026 |
| Outcome of Board Meeting without Intimation | ||
| Board Meeting | 4 May 2026 | 27 Apr 2026 |
| Jyothy Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/05/2026 inter alia to consider and approve the Audited Financial Results of the Company for the quarter and year ended March 31 2026 together with the Auditors Reports thereon by the Statutory Auditors of the Company; and recommend dividend if any on the equity shares of the Company for the financial year 2025-26 Outcome of Board Meeting held on May 04, 2026 (As Per BSE Announcement Dated on: 04/05/2026) | ||
| Board Meeting | 9 Feb 2026 | 2 Feb 2026 |
| Jyothy Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2026 ,inter alia, to consider and approve Un-audited Financial Results of the Company for the quarter and nine months ended December 31, 2025, with limited review thereon by the Statutory Auditors of the Company. Unaudited Financial Results For The quarter and nine months ended December 31, 2025. (As per BSE announcement dated on : 09.02.2026) | ||
| Board Meeting | 12 Nov 2025 | 5 Nov 2025 |
| Jyothy Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2025 inter alia to consider and approve the Un-audited Financial Results of the Company for the quarter and half year ended September 30 2025 with limited review thereon by the Statutory Auditors of the Company. Unaudited Financial Results For The quarter and half year ended September 30, 2025 (As per BSE Announcement dated on: 12.11.2025) | ||
| Board Meeting | 12 Aug 2025 | 4 Aug 2025 |
| Jyothy Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2025 inter alia to consider and approve Un-Audited Financial Results For The Quarter Ended June 30 2025. Outcome of Board Meeting held on August 12, 2025 (As Per BSE Announcement Dated on: 12/08/2025) | ||
Operating performance was marginally improved with EBITDA increasing by 3.1% to ₹112 crore in Q4 FY25 from ₹108.5 crore in the same quarter last year
The sale was approved by the Board of Directors at a meeting held on March 25, 2025. Post sale, JKBL ceases to be a subsidiary of Jyothy Labs.
Operating EBITDA grew by 2.3% YoY, reaching ₹138.5 Crore, up from ₹135.4 Crore in the previous year’s Q2.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
